Aarti Pharmalabs Limited has submitted a regulatory filing to both BSE Limited and the National Stock Exchange of India Limited regarding the availability of its earnings conference call recording.
The disclosure is made pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. This communication serves as a continuation of the company's previous intimation dated October 22, 2026, which announced an Investors/Analyst Earnings Conference Call to discuss the company's Unaudited Financial Results for the second quarter ended September 30, 2026.
The company has now uploaded the audio recording of this earnings conference call to its official website. The recording is accessible to the public at the following specific URL: https://www.aartipharmalabs.com/q2-fy-27/.
The letter is signed by Jeevan Bhargav Mondkar, who holds the positions of Company Secretary and Legal Head at Aarti Pharmalabs Limited. Mr. Mondkar is a member of the Institute of Company Secretaries of India (ICSI) with membership number A22565. The document was digitally signed on October 29, 2026, at 18:20:09 IST.